RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
multi- center, randomized, blinded comparative
study of nasolabial fold
treatments reporting ... reach full correction in this split-face trial comparative
In conclusion, the study authors noted ... Restylane Clinical Trial
A 60-patient blinded, comparative
split-face study was conducted at two
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
... of a multi-center,
randomized, blinded comparative
study of nasolabial fold treatments
reporting ... filler options.
The published report of the comparative
study of Radiesse against leading
hyaluronic acid ... and Perlane Clinical Trial
A 205-patient comparative
study was conducted at five clinical sites ...
New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation
... treat a type of irregular heartbeat known as atrial fibrillation. The new comparative
effectiveness report found that the procedure has been shown to provide ... .
AHRQ's new report, comparative
Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation, ...
New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
... and one of the study researchers. "It's also the first time that a comparative
analysis has been done looking at various SSRIs and what's clear is that ... CYP2D6 inhibitor drugs are present, and it is the first study to show the comparative
impact of various antidepressants on breast cancer recurrence.
PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
... administration in less than 2.5 minutes.
IsoCrom & ICS comparative
Data from a randomized, open-label, Phase II, six-month ... treatment with either inhaled corticosteroids or IsoCrom.
in-vitro assessment of IsoCrom & a novel 6% DSCG formulation
Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed
... best approaches to improving patient care, analyzed recent studies on the comparative
effectiveness of CT colonography to traditional colonoscopy. Researchers ... Assessment Information Service(TM), or for information about other comparative
effectiveness reviews and health technology assessment services , e-mail ...
The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
... been clinically tested and shown to improve the appearance of scars in a comparative
study. The Agreement is with Levlad, LLC/Natures Gate, ... this compound showed an improvement in the visual appearance of scars in a comparative
study versus a category leading OTC national brand name scar cream.
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Phase 2 REVEAL-1 Trial
Researchers presented an analysis of comparative
pharmacokinetic and response data from Sunesis' Phase 1 ... that can be tolerated by older patients remains unmet. Results from
analysis demonstrate that voreloxin is generally well
tolerated and ...
Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
WARSAW, Ind., July 20 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) today announced that data from a comparative
clinical study conducted by researchers at the Mayo Clinic and the Joint Replacement Surgeons of the Indiana Research Foundation describes the low ...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
... (SNP) genotyping and allelotyping, copy number variation analysis, quantitative gene expression analysis, quantitative methylation marker analysis, comparative
sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control.
SEQUENOM is a life sciences ...
Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative
... A mission-driven, values-based organizational culture brings people together to achieve higher performance.
Clinical dashboards communicate comparative
physician performance. Performance-based pay rewards achievement on quality, patient satisfaction, productivity, and engagement.
Spherix Announces Positive Phase 2 Study Results
Type 2 diabetes mellitus (T2DM) is a disease that is characterized by elevated blood glucose in the context of insulin resistance and comparative
insulin deficiency. While T2DM is often initially managed by increasing exercise in conjunction with dietary modification, medications are usually ...
Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
... The microfracture technique is the current standard for articular cartilage treatment. The second study, performed in collaboration with the comparative
Orthopaedic Research Laboratory at the New Bolton Center of the University of Pennsylvania School of Veterinary Medicine , examined the CRD in a ...
Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop
... of Cinryze in Pigs
From the laboratory of Dr. Michael Frank at Duke University , Dr. H. Jiang et al. described the results of a comparative
pharmacokinetic study of subcutaneous and intravenous doses of C1 Inhibitor in an abstract entitled, 'Subcutaneous (SQ) Versus Intravenous (IV) ...
NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology
... is a minimally invasive treatment for patients suffering with symptomatic varicose veins and venous reflux, and has been demonstrated in numerous comparative
studies to offer advantages over conventional vein stripping surgery. The technique will be showcased at the NHS EXPO Meeting on June 18-19, 2009.
Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
... a weight gain of 7.4 pounds for pioglitazone.
"Recognizing the importance of A1C control, it has become clear that health care providers need comparative
data to better understand the relative value of therapeutic options," said Richard Bergenstal, M.D., executive director of the International Diabetes ...
AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents
... supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology's National Cardiovascular Data Registry.
effectiveness study of 262,700 Medicare patients who received stents - spring-like tubes to keep heart vessels open - is the largest ever to compare ...
Astrocytes Help Separate Man From Mouse
... Ph.D., professor and chair of Neurology; Webster Pilcher, M.D., professor and chair of Neurosurgery; Jeffrey Wyatt, D.V.M., professor and chair of comparative
Medicine; and research assistant professors Takahiro Takano, Ph.D., Xiaoning Han, Ph.D., Wei He, Ph.D., and Fushun Wang, Ph.D.
Other authors ...
Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
... (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its ClariSure(TM) microarray-based comparative
genomic hybridization (aCGH) postnatal test is now available for testing on patients in the state of New York. With licensure by the State Department ...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... CUR) made synaptic contacts with the motor neurons of rats with ALS-like symptoms, a paper published in the current online edition of the Journal of comparative
Neurology reported. This constitutes evidence that the transplanted cells integrated into the nervous system of the host. The rats had a genetic ...
Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology
... ZMH ; SWX: ZMH), a leader in the orthopaedic industry, today announced that data from an independent 10-year Trabecular Metal (TM) Technology comparative
clinical study demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology. The study found bone-to-implant gap-filling ...
Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
... The other three treatment arms remained blinded. Subsequent analyses were designed to estimate the extent to which the crossover affected the comparative
benefit of Femara(1).
With the long-term follow-up in the analysis conducted more than 10 years after the start of the study, adverse events ...
Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
... that can lead to renal failure if not controlled.
The primary objective of the multi-center, open-label, randomized, parallel group comparative
study was to compare the adequacy of control of PUA concentration and the safety profile in three treatment arms. Among the three treatment arms, ...
Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
... in least painful testing, we are helping to remove one of the barriers
to adequate testing for improved diabetes management."
pain study was conducted by Dr. Richard Koubek, of Koubek
and Associates, on behalf of Roche.
About Roche Diabetes Care
Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
... Triage Study (ALTS), the Cervista
HPV high-risk test has a comparable specificity to the test used in that
study. The ALTS trial is the best comparative
trial for the Cervista HPV
high-risk trial based on similarities in trial design.
The Cervista HPV high-risk test has additional advantages ...
Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
... mg twice daily
uSSSI Phase 2 Trial Design
This Phase 2 trial, which enrolled 150 patients, was a multicenter,
randomized, open-label, comparative
study conducted at 19 clinical centers
across the U.S. to evaluate the safety and efficacy of radezolid versus
linezolid in the outpatient treatment ...
Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
... test-of-cure (TOC) visit (7 to 14 days post treatment) and at a late
follow-up visit 7 to 14 days after the TOC visit. The primary endpoint was
clinical cure rates of iclaprim and linezolid at the TOC
visit in the ITT and PP populations.
The most commonly reported adverse events in the ...
Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
... and Chemotherapy (ICAAC), taking place
in Washington, D.C.
Paratek's U.S.-based Phase 2 multi-center, randomized (1:1),
trial enrolled 234 patients with cSSSI
who required initial IV therapy. Patients were randomized to receive up to
14-days of therapy of either PTK ...
Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
... including penicillin, macrolide and quinolone resistant strains.
The NXL103 Phase II study was a double-blind, multinational,
study that evaluated this novel oral antibacterial
as a treatment for mild to moderate CAP. The study recruited 300 adult
patients in 9 countries in ...
PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
... Fellowship at the University of California, Los
Angeles Medical School and clinical associate professor of surgery at UCLA.
"The findings of this comparative
preclinical study demonstrate that the
PlasmaBlade Needle causes less thermal tissue damage than traditional
electrosurgery because it cuts and ...
Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels
... insulin analogues are associated with a higher frequency
of hypoglycemic events than oral antidiabetic (non-insulin) agents are.
The report, comparative
Effectiveness, Safety and Indications of
Pre-mixed Insulin Analogues for Adults With Type 2 Diabetes, is available
at effectivehealthcare.ahrq.gov. ...
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
... positive results announced for this
vaccine in June 2008. The data were derived from a histopathological
analysis of tissues samples collected in comparative
studies of CEL-2000
and Enbrel(R) that were conducted in a well established animal model of
rheumatoid arthritis. Enbrel is a leading treatment for ...
Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
... by Daiichi Sankyo Company, Limited (TSE: 4568) and the
data were presented by lead investigator Dr. Gary Raskob.
This randomized, double-blind comparative
study examined the safety and
efficacy of four doses of DU-176b (15, 30, 60 and 90 mg once daily) versus
the low molecular weight heparin, ....
TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
... inhibitor therapy. A review of the literature
and pathophysiology. Ann Intern Med 1992; 117(3):234-42.
(5) Matchar DB, et al. Systematic Review: comparative
angiotensin-converting enzyme inhibitors and angiotensin II receptor
blockers for treating essential hypertension. Ann Intern Med ...
Shingles Pain Treatment Will Benefit More Patients
... SMC decision (issued in February 2007) for
Versatis (5% lidocaine medicated plaster) is based on significant new
clinical and cost-effectiveness comparative
data and brings prescribing
availability of the treatment in line with England and Wales. These new
data on Versatis will be presented for the first ...
Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
... EVP, Chief Medical Officer of Cell Therapeutics. "A
standard-of-care arm (doxorubicin) is included as a reference arm, although
not used to determine comparative
efficacy. If the study results are
encouraging, a Phase III study in soft tissue sarcoma could be initiated in
The title of the trial is ...
Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
... profile to dosing with INS-19 as with
Neupogen(R). These human INS-19 and Neupogen(R) data complement Insmed's
extensive analytical testing and comparative
data from pre-clinical
"These results are very exciting, as they represent Insmed's ability to
replicate a protein product, to bring ...
Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
... 96-week comparative
study of Clevudine versus Viread(R) versus Clevudine+Viread(R) in 150 patients with chronic hepatitis B
PRINCETON, N.J., July 8 ...
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
... to building a robust antibiotic
Design and Results
The two globally conducted, multi-center, Phase III, randomized,
studies were designed to evaluate the efficacy and
safety of ceftaroline compared to vancomycin plus aztreonam. The data were
collected from 1396 ...
New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
... also announced today the first and only full scale study
of once-daily Levemir versus a single daily dose of glargine to generate
the first robust comparative
data set of the two treatments.
"By finally establishing the efficacy profiles of these drugs in a
direct and fair comparison, we will help ...